Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18436821 | METHODS FOR EARLY DETECTION OF CANCER | February 2024 | August 2024 | Allow | 6 | 1 | 0 | No | No |
| 18535812 | SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION | December 2023 | August 2024 | Allow | 9 | 1 | 0 | No | No |
| 18319889 | NUCLEIC ACID LIBRARY METHODS | May 2023 | October 2023 | Allow | 5 | 1 | 0 | No | No |
| 18156890 | METHODS FOR EARLY DETECTION OF CANCER | January 2023 | July 2023 | Allow | 6 | 1 | 1 | Yes | No |
| 18154630 | METHODS AND COMPOSITIONS FOR SEQUENCING COMPLEMENTARY POLYNUCLEOTIDES | January 2023 | November 2023 | Allow | 10 | 1 | 0 | No | No |
| 18152554 | PRIMER-PROBE COMBINATION AND KIT FOR VAGINAL MICROECOSYSTEM DETECTION | January 2023 | January 2024 | Allow | 12 | 1 | 1 | No | No |
| 17924359 | DIGITAL NUCLEIC ACID AMPLIFICATION TESTING METHOD AND INTEGRATED DETECTION SYSTEM BASED ON CRISPR-CAS TECHNOLOGY | November 2022 | September 2023 | Allow | 10 | 1 | 0 | No | No |
| 18048808 | METHODS AND COMPOSITIONS FOR SEQUENCING COMPLEMENTARY POLYNUCLEOTIDES | October 2022 | August 2023 | Allow | 10 | 1 | 0 | No | No |
| 18047979 | METHODS FOR EARLY DETECTION OF CANCER | October 2022 | June 2023 | Allow | 8 | 2 | 0 | No | No |
| 17961571 | METHOD FOR DETECTING CANCER USING 5-HYDROXYMETHYLCYTOSINE (5-hmC) | October 2022 | July 2023 | Allow | 9 | 1 | 0 | No | No |
| 17900619 | METHOD FOR NUCLEIC ACID AMPLIFICATION | August 2022 | December 2022 | Allow | 4 | 0 | 0 | Yes | No |
| 17844498 | Method and Kit of Detecting the Absence of Micro-Organisms | June 2022 | April 2023 | Allow | 10 | 2 | 1 | Yes | No |
| 17840490 | METHODS AND COMPOSITIONS FOR SEQUENCING COMPLEMENTARY POLYNUCLEOTIDES | June 2022 | December 2022 | Allow | 6 | 1 | 1 | No | No |
| 17837375 | METHODS FOR COMPUTER PROCESSING SEQUENCE READS TO DETECT MOLECULAR RESIDUAL DISEASE | June 2022 | October 2022 | Allow | 4 | 1 | 0 | No | No |
| 17833702 | Transposition of Native Chromatin for Personal Epigenomics | June 2022 | October 2022 | Allow | 4 | 1 | 0 | No | No |
| 17833686 | Transposition of Native Chromatin for Personal Epigenomics | June 2022 | October 2022 | Allow | 4 | 1 | 0 | Yes | No |
| 17700257 | METHODS FOR ANALYZING NUCLEIC ACIDS | March 2022 | November 2022 | Allow | 8 | 1 | 0 | Yes | No |
| 17688241 | METHOD FOR TRANSPOSASE-MEDIATED SPATIAL TAGGING AND ANALYZING GENOMIC DNA IN A BIOLOGICAL SAMPLE | March 2022 | July 2022 | Allow | 5 | 1 | 0 | No | No |
| 17688762 | METHODS FOR EARLY DETECTION OF CANCER | March 2022 | February 2023 | Allow | 11 | 2 | 0 | No | No |
| 17666458 | METHODS AND COMPOSITIONS FOR SEQUENCING COMPLEMENTARY POLYNUCLEOTIDES | February 2022 | September 2022 | Allow | 7 | 1 | 1 | No | No |
| 17577033 | METHOD FOR DETECTING CANCER USING 5-HYDROXYMETHYLCYTOSINE (5-hmC) | January 2022 | December 2022 | Abandon | 11 | 1 | 0 | No | No |
| 17507109 | METHODS FOR DETECTING SINGLE NUCLEOTIDE VARIANTS OR INDELS BY DEEP SEQUENCING | October 2021 | March 2022 | Allow | 5 | 2 | 0 | No | No |
| 17494669 | Computational Method for Detecting Fusion Events | October 2021 | May 2024 | Allow | 31 | 1 | 1 | No | No |
| 17396097 | SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION | August 2021 | January 2022 | Allow | 6 | 1 | 0 | No | No |
| 17367245 | METHODS FOR COMPUTER PROCESSING SEQUENCE READS TO DETECT MOLECULAR RESIDUAL DISEASE | July 2021 | February 2022 | Allow | 8 | 1 | 0 | No | No |
| 17338922 | AFFINITY MEDIATED TRANSPORT AMPLIFICATION | June 2021 | February 2022 | Allow | 8 | 1 | 1 | No | No |
| 17202903 | A METHOD FOR POC-BASED DETECTION OF PATHOGENIC INFECTION VIA NUCLEIC ACID BASED TESTING | March 2021 | November 2023 | Allow | 32 | 5 | 1 | Yes | No |
| 17197236 | COMPOSITIONS AND METHODS FOR THE DETECTION AND ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS | March 2021 | November 2023 | Allow | 32 | 1 | 0 | No | No |
| 17184201 | METHODS FOR SEQUENCING BIOPOLYMERS | February 2021 | October 2023 | Allow | 32 | 1 | 0 | No | No |
| 17173006 | MEASUREMENT OF NUCLEIC ACID VARIANTS USING HIGHLY-MULTIPLEXED ERROR-SUPPRESSED DEEP SEQUENCING | February 2021 | March 2024 | Abandon | 37 | 1 | 1 | No | No |
| 17154313 | MOLECULAR QUALITY ASSURANCE METHODS FOR USE IN SEQUENCING | January 2021 | April 2024 | Abandon | 39 | 1 | 1 | No | No |
| 17151023 | METHODS AND MATERIALS FOR DETECTING CONTAMINATED FOOD PRODUCTS | January 2021 | November 2023 | Abandon | 34 | 1 | 0 | No | No |
| 17144046 | METHODS AND COMPOSITIONS FOR IN VIVO SCREENING OF THERAPEUTICS THROUGH SPATIAL TRANSCRIPTOMICS | January 2021 | April 2023 | Allow | 27 | 1 | 1 | Yes | No |
| 17138996 | TEMPERATURE CONTROLLED DNA POLYMERASE INHIBITORS | December 2020 | July 2024 | Abandon | 42 | 0 | 1 | No | No |
| 17130394 | METHODS AND APPARATUS FOR SEQUENTIAL AMPLIFICATION REACTIONS | December 2020 | March 2024 | Allow | 39 | 2 | 0 | No | No |
| 17120500 | DETECTING COLORECTAL NEOPLASM | December 2020 | January 2024 | Allow | 37 | 2 | 0 | No | No |
| 17252222 | A SYSTEM FOR IDENTIFICATION OF ANTIGENS RECOGNIZED BY T CELL RECEPTORS EXPRESSED ON TUMOR INFILTRATING LYMPHOCYTES | December 2020 | November 2022 | Allow | 23 | 1 | 0 | No | No |
| 17114622 | HIGH DENSITY SELF-CONTAINED BIOLOGICAL ANALYSIS | December 2020 | September 2023 | Allow | 33 | 1 | 0 | No | No |
| 17114455 | PORTABLE GENOME SEQUENCING AND GENOTYPING DEVICE AND OPERATING METHOD THEREOF | December 2020 | October 2023 | Allow | 34 | 1 | 0 | Yes | No |
| 16976128 | METHOD FOR THE AMPLIFICATION OF A NUCLEIC ACID WITH IMPROVED SPECIFICITY | November 2020 | June 2024 | Abandon | 45 | 0 | 1 | No | No |
| 17094908 | ASSAY FOR DETECTING CLOSELY-RELATED SEROTYPES OF HUMAN PAPILLOMAVIRUS (HPV) | November 2020 | October 2023 | Allow | 35 | 1 | 1 | No | No |
| 17054293 | Methods for Microbial Identification in Clinical Specimens by Differential Ribosomal RNA Probe Hybridization | November 2020 | November 2023 | Abandon | 36 | 1 | 1 | No | No |
| 17070843 | SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION | October 2020 | June 2021 | Allow | 8 | 1 | 0 | No | No |
| 17069535 | SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION | October 2020 | September 2021 | Allow | 11 | 2 | 0 | No | No |
| 17069559 | SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION | October 2020 | June 2021 | Allow | 9 | 2 | 0 | No | No |
| 16948442 | NOVEL COMPOSITIONS, METHODS AND KITS FOR ENHANCING PCR SPECIFICITY | September 2020 | June 2022 | Allow | 21 | 2 | 1 | No | No |
| 17020804 | METHODS AND REAGENTS FOR NUCLEIC ACIDS DETECTION | September 2020 | November 2023 | Allow | 38 | 3 | 1 | Yes | No |
| 17014322 | METHOD FOR DETECTING SINGLE STRAND BREAKS IN DNA | September 2020 | October 2023 | Allow | 37 | 2 | 0 | No | No |
| 17013222 | MULTIPLEX DROP-OFF DIGITAL POLYMERASE CHAIN REACTION METHODS | September 2020 | March 2021 | Allow | 60 | 0 | 0 | Yes | No |
| 17010410 | Multipurpose Compositions for Collecting and Transporting Biological Material | September 2020 | September 2023 | Allow | 36 | 3 | 1 | Yes | No |
| 17002559 | Method and Kit of Detecting the Absence of Micro-Organisms | August 2020 | July 2022 | Abandon | 23 | 1 | 1 | No | No |
| 17001458 | METHOD TO AMPLIFY TRANSVERSE TUNNELING CURRENT DISCRIMINATION OF DNA NUCLEOTIDES VIA NUCLEOTIDE SITE SPECIFIC ATTACHMENT OF DYE-PEPTIDE | August 2020 | March 2022 | Allow | 19 | 1 | 0 | No | No |
| 16984927 | Rapid PCR-Based Virus Detection Method, and Kits therefor | August 2020 | January 2021 | Allow | 6 | 1 | 0 | Yes | No |
| 16965796 | METHOD FOR NUCLEIC ACID AMPLIFICATION | July 2020 | August 2023 | Allow | 37 | 1 | 1 | Yes | No |
| 16939098 | PRIMER SET AND METHOD FOR DETECTING TELOMERASE ACTIVITY | July 2020 | September 2023 | Allow | 37 | 1 | 1 | No | No |
| 16935111 | DNA SEQUENCING VIA DIRECT ELECTRICAL DETECTION WITH FREE SINGLE NUCLEOTIDE PAIRING WITH POLYMERASE | July 2020 | May 2022 | Allow | 22 | 1 | 1 | Yes | No |
| 16930562 | KITS AND METHODS FOR PATHOGEN DETECTION | July 2020 | September 2022 | Allow | 26 | 1 | 1 | Yes | No |
| 16927303 | INTEGRATED THERMOPLASTIC CHIP FOR RAPID PCR AND HRMA | July 2020 | May 2023 | Allow | 34 | 2 | 1 | No | No |
| 16918924 | Transposition of Native Chromatin for Personal Epigenomics | July 2020 | September 2020 | Allow | 2 | 1 | 0 | No | No |
| 16913965 | SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION | June 2020 | February 2022 | Allow | 19 | 4 | 0 | No | No |
| 16908020 | COMPOSITIONS AND METHODS FOR USE IN A PCR ASSAY FOR DETERMINING THE GENOTYPE AND VIRAL LOAD FOR RESPIRATORY SYNCYTIAL VIRUS | June 2020 | January 2023 | Allow | 31 | 2 | 1 | No | No |
| 16892660 | METHOD FOR ANALYZING A NUCLEIC ACID SEQUENCE | June 2020 | March 2023 | Allow | 33 | 2 | 0 | Yes | No |
| 16887024 | MICROFLUIDIC SURFACE-MEDIATED EMULSION STABILITY CONTROL | May 2020 | November 2021 | Allow | 17 | 1 | 0 | No | No |
| 16884518 | METHODS AND COMPOSITIONS FOR TAGGING AND ANALYZING SAMPLES | May 2020 | June 2021 | Allow | 13 | 0 | 0 | No | No |
| 16884528 | Methods and Processes for Non-Invasive Assessment of Genetic Variations | May 2020 | December 2021 | Allow | 19 | 1 | 0 | Yes | No |
| 16884343 | SAMPLE SERIES TO DIFFERENTIATE TARGET NUCLEIC ACIDS FROM CONTAMINANT NUCLEIC ACIDS | May 2020 | February 2023 | Allow | 33 | 1 | 0 | Yes | No |
| 16766928 | RNA Printing and Sequencing Devices, Methods, and Systems | May 2020 | May 2023 | Allow | 36 | 1 | 1 | Yes | No |
| 16882289 | METHOD AND APPARATUS FOR SIMULTANEOUS TARGETED SEQUENCING OF DNA, RNA AND PROTEIN | May 2020 | May 2022 | Allow | 23 | 1 | 0 | Yes | No |
| 16869720 | METHODS FOR ISOLATING A TARGET NUCLEIC ACID FROM RED BLOOD CELLS | May 2020 | September 2021 | Allow | 16 | 1 | 0 | Yes | No |
| 16870476 | SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION | May 2020 | October 2020 | Allow | 6 | 1 | 0 | No | No |
| 16761686 | COMPOSITIONS AND METHODS FOR DETECTION OF MICROORGANISMS | May 2020 | March 2022 | Allow | 22 | 1 | 0 | Yes | No |
| 16865061 | Barcoded Solid Supports and Methods of Making and Using Same | May 2020 | August 2022 | Allow | 28 | 1 | 1 | No | No |
| 16758283 | PREPARATION METHOD FOR IN-SITU HYBRIDIZATION PROBE | April 2020 | January 2022 | Allow | 21 | 1 | 0 | Yes | No |
| 16853241 | SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION | April 2020 | October 2020 | Allow | 6 | 1 | 0 | Yes | No |
| 16844675 | Nucleic Acid Melting Analysis with Saturation Dyes | April 2020 | January 2022 | Allow | 21 | 1 | 0 | No | No |
| 16842089 | Assays for Single Molecule Detection and Use Thereof | April 2020 | December 2021 | Allow | 21 | 1 | 0 | Yes | No |
| 16839058 | METHOD AND SYSTEMS TO CHARACTERIZE TUMORS AND IDENTIFY TUMOR HETEROGENEITY | April 2020 | October 2023 | Abandon | 42 | 1 | 1 | No | No |
| 16834933 | MASSIVELY MULTIPLEXED RNA SEQUENCING | March 2020 | November 2022 | Allow | 32 | 2 | 0 | No | No |
| 16823610 | SEQUENCING METHOD EMPLOYING TERNARY COMPLEX DESTABILIZATION TO IDENTIFY COGNATE NUCLEOTIDES | March 2020 | August 2021 | Allow | 17 | 2 | 0 | No | No |
| 16824413 | METHODS AND SYSTEMS FOR DETECTING TISSUE CONDITIONS | March 2020 | February 2022 | Abandon | 23 | 1 | 0 | No | No |
| 16824417 | METHODS OF ANALYZING NUCLEIC ACID FRAGMENTS | March 2020 | March 2022 | Abandon | 24 | 1 | 1 | No | No |
| 16816350 | PCR APPARATUS FOR REAL-TIME DETECTING OF ONE OR MORE FLUORESCENT SIGNALS | March 2020 | April 2023 | Allow | 37 | 2 | 0 | Yes | No |
| 16809375 | METHODS FOR RNA ANALYSIS | March 2020 | March 2023 | Abandon | 37 | 2 | 1 | No | No |
| 16642400 | PREGNANCY TREATMENT IN RUMINANT | February 2020 | August 2024 | Abandon | 54 | 4 | 1 | Yes | No |
| 16637586 | IN VITRO ISOLATION AND ENRICHMENT OF NUCLEIC ACIDS USING SITE-SPECIFIC NUCLEASES | February 2020 | April 2022 | Allow | 26 | 1 | 0 | No | No |
| 16637462 | Method for Detecting a Microorganism in a Sample | February 2020 | March 2022 | Allow | 25 | 2 | 0 | No | No |
| 16779597 | Multiplex Nucleic Acid Amplification and Library Preparation | February 2020 | May 2022 | Allow | 27 | 1 | 0 | Yes | No |
| 16635131 | NUCLEIC ACID SEQUENCING METHOD | January 2020 | February 2023 | Allow | 36 | 1 | 1 | Yes | No |
| 16752277 | NUCLEIC ACID COMPLEX PAIR, COMPETITIVE CONSTRUCT, AND PCR KIT USING THE SAME | January 2020 | February 2021 | Allow | 12 | 2 | 0 | Yes | No |
| 16741471 | METHODS, COMPOSITIONS AND KITS FOR SMALL RNA CAPTURE, DETECTION AND QUANTIFICATION | January 2020 | October 2021 | Allow | 21 | 1 | 0 | Yes | No |
| 16738718 | DETECTING COLORECTAL NEOPLASM | January 2020 | August 2020 | Allow | 8 | 0 | 0 | No | No |
| 16723975 | Use Of FGFR Mutant Gene Panels In Identifying Cancer Patients That Will Be Responsive To Treatment With An FGFR Inhibitor | December 2019 | April 2024 | Abandon | 52 | 5 | 1 | Yes | No |
| 16719863 | HIGH THROUGHPUT SCREENING OF POPULATIONS CARRYING NATURALLY OCCURRING MUTATIONS | December 2019 | January 2023 | Allow | 37 | 4 | 0 | No | No |
| 16711892 | SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION | December 2019 | November 2023 | Allow | 47 | 3 | 0 | No | No |
| 16707780 | SELECTIVE EXTENSION IN SINGLE CELL WHOLE TRANSCRIPTOME ANALYSIS | December 2019 | July 2022 | Allow | 31 | 2 | 0 | Yes | No |
| 16701087 | IN SITU READOUT OF DNA BARCODES | December 2019 | April 2022 | Allow | 28 | 1 | 0 | No | No |
| 16615872 | Multiplex End-Tagging Amplification of Nucleic Acids | November 2019 | August 2022 | Allow | 33 | 1 | 1 | Yes | No |
| 16687804 | REACTION PROCESSOR | November 2019 | August 2022 | Allow | 33 | 1 | 0 | Yes | No |
| 16677451 | DIRECT RNA NANOPORE SEQUENCING WITH HELP OF A STEM-LOOP REVERSE POLYNUCLEOTIDE | November 2019 | July 2022 | Allow | 32 | 1 | 1 | Yes | No |
| 16611563 | MULTIPLEX DETECTION OF BACTERIAL PATHOGENS VIA CELL WALL BINDING DOMAIN COMPLEXES | November 2019 | October 2023 | Allow | 47 | 2 | 1 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner WILDER, CYNTHIA B.
With a 30.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 10.4% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner WILDER, CYNTHIA B works in Art Unit 1637 and has examined 963 patent applications in our dataset. With an allowance rate of 55.6%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 32 months.
Examiner WILDER, CYNTHIA B's allowance rate of 55.6% places them in the 10% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by WILDER, CYNTHIA B receive 1.77 office actions before reaching final disposition. This places the examiner in the 53% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by WILDER, CYNTHIA B is 32 months. This places the examiner in the 30% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +46.0% benefit to allowance rate for applications examined by WILDER, CYNTHIA B. This interview benefit is in the 92% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 23.2% of applications are subsequently allowed. This success rate is in the 22% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 42.9% of cases where such amendments are filed. This entry rate is in the 59% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 68% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 65.5% of appeals filed. This is in the 41% percentile among all examiners. Of these withdrawals, 68.4% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 41.4% are granted (fully or in part). This grant rate is in the 42% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 3.9% of allowed cases (in the 86% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 1.9% of allowed cases (in the 64% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.